|
Volumn 293, Issue 1, 2002, Pages 566-571
|
Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol
|
Author keywords
Bioinformatics; CDK; Drug design; Flavopiridol; Structure
|
Indexed keywords
2,6 DIAMINO 4 CYCLOHEXYLMETHOXY 5 NITROSOPYRIMIDINE;
6 N (3,3 DIMETHYLALLYL)ADENINE;
6 O CYCLOHEXYLMETHYLGUANINE;
ADENINE DERIVATIVE;
ADENOSINE TRIPHOSPHATE;
CYCLIN DEPENDENT KINASE;
CYCLIN DEPENDENT KINASE 2;
CYCLIN DEPENDENT KINASE 9;
CYCLIN T1;
DECHLOROFLAVOPIRIDOL;
ENZYME INHIBITOR;
FLAVONE DERIVATIVE;
FLAVOPIRIDOL;
HYMENIALDISINE;
INDIRUBIN;
OLOMOUCINE;
PKFO 49 38;
PURVALANOL B;
ROSCOVITINE;
STAUROSPORINE;
U 55;
UNCLASSIFIED DRUG;
ARTICLE;
CORRELATION ANALYSIS;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG STRUCTURE;
ENZYME INHIBITION;
IC 50;
MOLECULAR MODEL;
PRIORITY JOURNAL;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
AMINO ACID SEQUENCE;
CYCLIN-DEPENDENT KINASE 9;
CYCLIN-DEPENDENT KINASES;
ENZYME INHIBITORS;
FLAVONOIDS;
MODELS, MOLECULAR;
MOLECULAR SEQUENCE DATA;
PIPERIDINES;
PROTEIN CONFORMATION;
SEQUENCE ALIGNMENT;
SEQUENCE HOMOLOGY, AMINO ACID;
|
EID: 0036295220
PISSN: 0006291X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-291X(02)00266-8 Document Type: Article |
Times cited : (131)
|
References (36)
|